BARCELONA, Spain, April 8 -- The Autonomous University of Barcelona issued the following news:

* * *

CAR therapies for neurodegeneration: a big challenge with increasingly plausible solutions

*

A UAB research team defines the criteria that CAR immunotherapies for neurodegenerative diseases must meet to advance both conceptually and in trials, which are still at a very preliminary stage, in a review study published in the journal Trends in Pharm . . .

Click here for more information about our products